CD4 and neoplasm: 4-1BB agonist antibody treatment induced widespread expression of the molecule killer cell lectin-like receptor subfamily G member 1 (KLRG1) as well as the co-inhibitory receptor programmed death 1 (PD-1) on tumor-infiltrating CD8+ and CD4+ effector T-cells.